A PHASE-II STUDY OF NEOCARZINOSTATIN (NSC 157365) IN MALIGNANT HEPATOMA - AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT-STUDY

被引：26

作者：

FALKSON, G

VONHOFF, D

KLAASSEN, D

DUPLESSIS, H

VANDERMERWE, CF

VANDERMERWE, AM

CARBONE, PP

机构：

[1] WISCONSIN CLIN CANC CTR,MADISON,WI

[2] NCI,WASHINGTON,DC

[3] UNIV PRETORIA,DEPT CANC CHEMOTHERAPY,PRETORIA,SOUTH AFRICA

[4] UNIV OTTAWA,OTTAWA K1N 6N5,ONTARIO,CANADA

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1980年 / 4卷 / 01期

关键词：

D O I：

10.1007/BF00255455

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 36

页数：4

共 14 条

[1]

COMIS RL, 1979, CANCER RES, V39, P757

[2]

FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO

[3]

2-5

[4]

GRIFFIN TW, 1978, CANCER TREAT REP, V62, P2019

[5]

ISHIDA N, 1965, J ANTIBIOT, V18, P68

[6]

ISHIDA N, 1960, GANN S, V51, P56

[7] NEOCARZINOSTATIN (NSC157365) A NEW CANCEROSTATIC COMPOUND [J].

LEGHA, SS ;

VONHOFF, DD ;

ROZENCWEIG, M ;

ABRAHAM, D ;

SLAVIK, M ;

MUGGIA, M .

ONCOLOGY, 1976, 33 (5-6) :265-270

[8]

OHNUMA T, 1978, CANCER, V42, P1670, DOI 10.1002/1097-0142(197810)42:4<1670::AID-CNCR2820420403>3.0.CO

[9]

2-E

[10]

RIVERA G, 1978, CANCER TREAT REP, V62, P2105

← 1 2 →